相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
Curtis J. Perry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
IMMUNOTHERAPY Cancer immunotherapy and the value of cure
Joseph C. Del Paggio
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The Aryl Hydrocarbon Receptor and Tumor immunity
Ping Xue et al.
FRONTIERS IN IMMUNOLOGY (2018)
We're Not DON Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
Kathryn M. Lemberg et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero et al.
NATURE MEDICINE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
Victor Prima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
Hayden Weng Siong Tan et al.
NATURE COMMUNICATIONS (2017)
Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Douglas E. Biancur et al.
NATURE COMMUNICATIONS (2017)
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
Pu-Ste Liu et al.
NATURE IMMUNOLOGY (2017)
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors
Shannon M. Steinberg et al.
CANCER RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
Discovery of 6-Diazo-5-oxo-L-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
Rana Rais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer
Nicholas C. D'Amato et al.
CANCER RESEARCH (2015)
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Yan Xiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages
Meera Rath et al.
FRONTIERS IN IMMUNOLOGY (2014)
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
Ang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
Rikke B. Holmgaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Metabolic targets for cancer therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Carmine Settembre et al.
EMBO JOURNAL (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Glutaminolysis Activates Rag-mTORC1 Signaling
Raul V. Duran et al.
MOLECULAR CELL (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Jian-Bin Wang et al.
CANCER CELL (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Ilaria Marigo et al.
IMMUNITY (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPβ-deficient hematopoietic cells
Tadayuki Akagi et al.
BLOOD (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Role of immature myeloid Gr-1+ cells in the development of antitumor immunity
QS Li et al.
CANCER RESEARCH (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
K Hoebe et al.
NATURE (2003)
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
GK Lee et al.
IMMUNOLOGY (2002)
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2002)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
